1.Adrenal myelolipoma and lipoma
Journal of Medical and Pharmaceutical Information 2005;0(12):35-39
Introduction: Adrenal myelolipomas and lipomas are extremely rare benign tumors. They are usually asymptomatic and in most cases are incidentally found at radiological examinations or autopsy. Symptoms such as abdominal pain and increasing girth occur only when the tumor grows large. Objectives: To evaluate and treat this situation. Subjects: We report the case of a giant adrenal myelolipoma with dimensions of 9 x 8 x 8cm and a giant adrenal lipoma with dimensions of 20 x16 x 12cm. Firstly, in a 48 year old man admitted to hospital on the 18 January 2005 without symtoms of adrenal lipoma or adrenal mylolipoma and another one is a 25 year old man who was hospitalized on the 8 December, 2004 with pain in the right hip since two months prior, normal blood pressure and undiscovered tumor by hand. Result: Other tests were normal. Looking at the CT scan images, a dark and consistent block located between the liver and right kidney can be seen. It pushed and turned the right kidney. Both of them were resected by laparoscopy. Conclusion: We discuss the prevalence, clinical features, diagnosis and treatment of these uncommon tumors.
Adrenal myelolipoma and lipoma
2.Study Design for the 2016 Baseline Survey of a Health System Strengthening Project in Quoc Oai District, Hanoi, Vietnam
Van Minh HOANG ; Juhwan OH ; Bao Ngoc NGUYEN ; Le Minh DAT ; Jong Koo LEE ; Thi Giang Huong TRAN ; Van Huy NGUYEN ; Seung Pyo LEE ; Kyung Sook BANG ; Youngtae CHO ; Sun Young KIM ; Hwa Young LEE ; Quang Cuong LE ; Narshil CHOI ; Thai Son DINH ; Ngoc Hoat LUU
Journal of Korean Medical Science 2019;34(5):e42-
BACKGROUND: In order to provide essential scientific evidence on the population's health status and social health determinants as well as the current capacity of the health care system in Vietnam to health policy makers and managers, Vietnam Ministry of Health, Hanoi University of Public Health, Hanoi Medical University, and Ho Chi Minh University of Medicine and Pharmacy collaborated with Seoul National University (Korea) and conducted a health system survey in the Quoc Oai district (of Hanoi capital) that represented northern rural Vietnam. METHODS: The study design was a cross-sectional study. The survey covered different topics (more than 200 questions) and was administered in three separate questionnaires: 1) Basic information of all household members; 2) Household characteristics; and 3) Individual characteristics. Socio-demographic characteristics among the households and individuals were collected from 2,400 households sampled by multi-stage cluster sampling method: more than 200 questions. RESULTS: The household size of Quoc Oai was larger than the national average and there was no significant difference in gender composition. In addition, the proportions of pre-elderly, age 55–64, and elderly group (65 years old and over) were higher than the national population statistics. In this context, demographic transition has begun in Quoc Oai. CONCLUSION: This study design description provides the basic information about a baseline survey of a future prospective cohort (as a part of a collaborative project on strengthening the health system in Vietnam) to the prospective data user of this survey.
Aged
;
Cohort Studies
;
Cross-Sectional Studies
;
Delivery of Health Care
;
Family Characteristics
;
Health Policy
;
Humans
;
Methods
;
Pharmacy
;
Population Characteristics
;
Population Dynamics
;
Prospective Studies
;
Public Health
;
Seoul
;
Surveys and Questionnaires
;
Vietnam
3. Favipiravir and its potentials in COVID-19 pandemic: An update
Dao TAM ; Ahmad QARAWI ; Mai LUU ; Gehad TAWFIK ; Le MINH ; Dao TAM ; Ahmad QARAWI ; Mai LUU ; Morgan TURNAGE ; Linh TRAN ; Linh TRAN ; Gehad TAWFIK ; Le MINH ; Nguyen HUY ; Kyoshi KITA ; Kenji HIRAYAMA ; Tatsuo IIYAMA
Asian Pacific Journal of Tropical Medicine 2021;14(10):433-439
The COVID-19 pandemic has caused millions of deaths and hundreds of millions of confirmed infections worldwide. This pandemic has prompted researchers to produce medications or vaccines to reduce or stop the progression and spread of this disease. A variety of previously licensed and marketed medications are being tested for the treatment and recurrence of SARS-CoV2, including favipiravir (Avigan). Favipiravir was recognized as an influenza antiviral drug in Japan in 2014, and has been known to have a potential in vitro activity against SARS-CoV-2, in addition to its broad therapeutic safety scope. Favipiravir was recently approved and officially used in many countries worldwide. Our review provides insights and up-to-date knowledge of the current role of favipiravir in the treatment of COVID-19 infection, focusing on preclinical and ongoing clinical trials, evidence of its efficacy against SARS-CoV-2 in COVID-19, side effects, anti-viral mechanism, and the pharmacokinetic properties of the drug in the treatment of COVID-19. Due to its teratogenic effects, favipiravir cannot be offered to expectant or pregnant mothers. The practical efficacy of such an intervention regimen will depend on its dose, treatment duration, and cost as well as difficulties in application.
4.Active case finding to detect symptomatic and subclinical pulmonary tuberculosis disease: implementation of computer-aided detection for chest radiography in Viet Nam
Anh L Innes ; Andres Martinez ; Gia Linh Hoang ; Thi Bich Phuong Nguyen ; Viet Hien Vu ; Tuan Ho Thanh Luu ; Thi Thu Trang Le ; Victoria Lebrun ; Van Chinh Trieu ; Nghi Do Bao Tran ; Nhi Dinh ; Huy Minh Pham ; Van Luong Dinh ; Binh Hoa Nguyen ; Thi Thanh Huyen Truong ; Van Cu Nguyen ; Viet Nhung Nguyen ; Thu Hien Mai
Western Pacific Surveillance and Response 2024;15(4):14-25
Objective: In Viet Nam, tuberculosis (TB) prevalence surveys revealed that approximately 98% of individuals with pulmonary TB have TB-presumptive abnormalities on chest radiographs, while 32% have no TB symptoms. This prompted the adoption of the “Double X” strategy, which combines chest radiographs and computer-aided detection with GeneXpert testing to screen for and diagnose TB among vulnerable populations. The aim of this study was to describe demographic, clinical and radiographic characteristics of symptomatic and asymptomatic Double X participants and to assess multilabel radiographic abnormalities on chest radiographs, interpreted by computer-aided detection software, as a possible tool for detecting TB-presumptive abnormalities, particularly for subclinical TB.
Methods: Double X participants with TB-presumptive chest radiographs and/or TB symptoms and known risks were referred for confirmatory GeneXpert testing. The demographic and clinical characteristics of all Double X participants and the subset with confirmed TB were summarized. Univariate and multivariable logistic regression modelling was used to evaluate associations between participant characteristics and subclinical TB and between computer-aided detection multilabel radiographic abnormalities and TB.
Results: From 2020 to 2022, 96 631 participants received chest radiographs, with 67 881 (70.2%) reporting no TB symptoms. Among 1144 individuals with Xpert-confirmed TB, 51.0% were subclinical. Subclinical TB prevalence was higher in older age groups, non-smokers, those previously treated for TB and the northern region. Among 11 computer-aided detection multilabel radiographic abnormalities, fibrosis was associated with higher odds of subclinical TB.
Discussion: In Viet Nam, Double X community case finding detected pulmonary TB, including subclinical TB. Computer-aided detection software may have the potential to identify subclinical TB on chest radiographs by classifying multilabel radiographic abnormalities, but further research is needed.